LUME-COLUMBUS Trademark

Trademark Overview

On Thursday, August 14, 2014, a trademark application was filed for LUME-COLUMBUS with the United States Patent and Trademark Office. The USPTO has given the LUME-COLUMBUS trademark a serial number of 86366455. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, September 22, 2023. This trademark is owned by Boehringer Ingelheim International GmbH. The LUME-COLUMBUS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical and scientific research in the field of oncology; providing medical and scientific research information in the field of pharmaceuticals and clinical trials
lume-columbus

General Information

Serial Number86366455
Word MarkLUME-COLUMBUS
Filing DateThursday, August 14, 2014
Status710 - CANCELLED - SECTION 8
Status DateFriday, September 22, 2023
Registration Number5156544
Registration DateTuesday, March 7, 2017
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 21, 2015

Trademark Statements

Goods and ServicesMedical and scientific research in the field of oncology; providing medical and scientific research information in the field of pharmaceuticals and clinical trials

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, September 22, 2023
Primary Code042
First Use Anywhere DateTuesday, December 1, 2015
First Use In Commerce DateTuesday, December 1, 2015

Trademark Owner History

Party NameBoehringer Ingelheim International GmbH
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressIngelheim
DE
Party NameBoehringer Ingelheim International GmbH
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIngelheim
DE
Party NameBoehringer Ingelheim International GmbH
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIngelheim
DE

Trademark Events

Event DateEvent Description
Friday, September 22, 2023CANCELLED SEC. 8 (6-YR)
Monday, March 7, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, March 7, 2017REGISTERED-PRINCIPAL REGISTER
Tuesday, January 31, 2017NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, January 30, 2017ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, June 13, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, June 13, 2016NON-FINAL ACTION E-MAILED
Monday, June 13, 2016SU - NON-FINAL ACTION - WRITTEN
Friday, May 20, 2016STATEMENT OF USE PROCESSING COMPLETE
Wednesday, May 18, 2016USE AMENDMENT FILED
Wednesday, May 18, 2016TEAS STATEMENT OF USE RECEIVED
Tuesday, February 2, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 1, 2016SOU EXTENSION 1 GRANTED
Wednesday, December 16, 2015SOU EXTENSION 1 FILED
Sunday, January 31, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, December 16, 2015SOU TEAS EXTENSION RECEIVED
Tuesday, June 16, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 21, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 21, 2015PUBLISHED FOR OPPOSITION
Wednesday, April 1, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, March 16, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, March 13, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, February 26, 2015AMENDMENT FROM APPLICANT ENTERED
Thursday, February 26, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 26, 2015ASSIGNED TO LIE
Wednesday, February 18, 2015PAPER RECEIVED
Wednesday, November 12, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, November 12, 2014NON-FINAL ACTION E-MAILED
Wednesday, November 12, 2014NON-FINAL ACTION WRITTEN
Friday, November 7, 2014ASSIGNED TO EXAMINER
Friday, August 22, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, August 18, 2014NEW APPLICATION ENTERED

Related Keywords

columbus lume medical research field scientific clinical trials pharmaceuticals oncology providing information